DK1915346T3 - Asymmetrisk katalytisk reduktion af oxcarbazepin - Google Patents

Asymmetrisk katalytisk reduktion af oxcarbazepin

Info

Publication number
DK1915346T3
DK1915346T3 DK06726863.1T DK06726863T DK1915346T3 DK 1915346 T3 DK1915346 T3 DK 1915346T3 DK 06726863 T DK06726863 T DK 06726863T DK 1915346 T3 DK1915346 T3 DK 1915346T3
Authority
DK
Denmark
Prior art keywords
oxcarbazepine
catalytic reduction
asymmetric catalytic
asymmetric
reduction
Prior art date
Application number
DK06726863.1T
Other languages
English (en)
Inventor
David Alexander Learmonth
Antonio Zanotti-Gerosa
Gabriela Alexandra Grasa
Original Assignee
Bial Portela & Ca Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34983785&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1915346(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bial Portela & Ca Sa filed Critical Bial Portela & Ca Sa
Application granted granted Critical
Publication of DK1915346T3 publication Critical patent/DK1915346T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
    • C07D223/28—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
    • C07D223/26—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a double bond between positions 10 and 11

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK06726863.1T 2005-07-29 2006-04-21 Asymmetrisk katalytisk reduktion af oxcarbazepin DK1915346T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0515690.6A GB0515690D0 (en) 2005-07-29 2005-07-29 Asymmetric catalytic reduction
PCT/GB2006/001473 WO2007012793A1 (en) 2005-07-29 2006-04-21 Asymmetric catalytic reduction of oxcarbazepine

Publications (1)

Publication Number Publication Date
DK1915346T3 true DK1915346T3 (da) 2011-12-05

Family

ID=34983785

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06726863.1T DK1915346T3 (da) 2005-07-29 2006-04-21 Asymmetrisk katalytisk reduktion af oxcarbazepin

Country Status (23)

Country Link
US (4) US8288532B2 (da)
EP (2) EP2319836B1 (da)
JP (2) JP5295765B2 (da)
KR (1) KR101362281B1 (da)
CN (1) CN101277937B (da)
AR (1) AR055917A1 (da)
AT (1) ATE520665T1 (da)
AU (1) AU2006273874B2 (da)
BR (1) BRPI0615970A8 (da)
CA (1) CA2616984C (da)
CY (1) CY1111988T1 (da)
DK (1) DK1915346T3 (da)
ES (2) ES2562816T3 (da)
GB (1) GB0515690D0 (da)
IL (1) IL189062A0 (da)
MX (1) MX2008001291A (da)
NZ (1) NZ565462A (da)
PL (1) PL1915346T3 (da)
PT (1) PT103467B (da)
RU (1) RU2439060C2 (da)
SI (1) SI1915346T1 (da)
WO (1) WO2007012793A1 (da)
ZA (1) ZA200800986B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
GB0515690D0 (en) 2005-07-29 2005-09-07 Portela & Ca Sa Asymmetric catalytic reduction
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
WO2010113179A2 (en) * 2009-04-02 2010-10-07 Glenmark Generics Limited A process for the purification of eslicarbazepine acetate
CA2769181C (en) 2009-07-27 2017-11-28 Bial-Portela & Ca., S.A. Use of 5h-dibenz / b, f/ azepine-5-carboxamide derivatives for treating fibromyalgia
WO2011091131A2 (en) * 2010-01-23 2011-07-28 Dr. Reddy's Laboratories Ltd. Eslicarbazepine acetate and its polymorphs
EP2383261B1 (en) 2010-04-23 2013-09-04 Euticals GmbH Process for the asymmetric hydrogenation of ketones
WO2011138795A2 (en) * 2010-05-03 2011-11-10 Msn Laboratories Limited Process for preparing (s)-10-acetoxy-10,11-dihydro-5h-dibenz[b,f] azepine-5-carboxamide
CN102250005B (zh) * 2010-05-19 2015-04-08 浙江九洲药物科技有限公司 艾利西平的制备方法
ES2687678T3 (es) 2011-03-08 2018-10-26 Jubilant Life Sciences Limited Procedimiento para la preparación de (S)-(+)-10,11-dihidro-10-hidroxi-5H-dibenzo[b,f]azepina-5-carboxamida y ésteres de la misma mediante reducción enantioselectiva de 10,11-dihidro-10-oxo-5H-dibenzo[b,f]azepina-5-carboxamida
EP2697662B1 (en) 2011-04-13 2018-06-06 Codexis, Inc. Biocatalytic process for preparing eslicarbazepine and analogs thereof
US20150065704A1 (en) 2011-07-13 2015-03-05 Ketan Hirpara Process for the preparation and purification of eslicarbazepine acetate and intermediates thereof
EP2900640A1 (en) 2012-09-26 2015-08-05 Ranbaxy Laboratories Limited Process for the preparation of oxcarbazepine and its use as intermediate in the preparation of eslicarbazepine acetate
EP3042902B1 (en) * 2013-09-06 2018-10-10 Nippon Soda Co., Ltd. Method for producing endo-9-azabicyclo[3.3.1]nonan-3-ol derivative
EP3064490A1 (en) 2015-03-06 2016-09-07 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of eslicarbazepine and eslicarbazepine acetate
LT3554490T (lt) 2016-12-16 2022-04-25 Idorsia Pharmaceuticals Ltd Farmacinis derinys, apimantis t tipo kalcio kanalo blokatorių

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT101732B (pt) * 1995-06-30 1997-12-31 Portela & Ca Sa Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
DE69634639T2 (de) 1995-12-06 2006-03-02 Japan Science And Technology Agency, Kawaguchi Verfahren zur herstellung optische aktive verbindungen
CA2374553A1 (fr) 1999-06-15 2000-12-21 Rhodia Chimie Sulfonylamides et carboxamides et leur application en catalyse asymetrique
GB0111566D0 (en) 2001-05-11 2001-07-04 Portela & Ca Sa Method for preparation of (s)-(+)-and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azephine-5-carboxamide
GB0112812D0 (en) 2001-05-25 2001-07-18 Portela & Ca Sa Mthd for preparation of 10, 11-dihydro-10-hydroxy-5H-dibenz/B,F/azepine-5-c arboxamide and 10,11-dihydro-10-oxo-5H-dibenz/B,F/azepine-5-carb oxamide therefrom
JP3504254B2 (ja) 2001-10-31 2004-03-08 関東化学株式会社 光学活性アミノアルコールおよびその中間体の製造方法
US6972275B2 (en) 2002-06-28 2005-12-06 Exxonmobil Research And Engineering Company Oil-in-oil emulsion lubricants for enhanced lubrication
GB0223224D0 (en) * 2002-10-07 2002-11-13 Novartis Ag Organic compounds
JP4309686B2 (ja) 2003-01-17 2009-08-05 関東化学株式会社 光学活性化合物の製造方法
GB2401605A (en) 2003-05-12 2004-11-17 Portela & Ca Sa Method for racemisation of (S)-(+)- and (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide and optically enriched mixtures thereof
CN1328252C (zh) * 2003-06-12 2007-07-25 中国科学院成都有机化学研究所 新型光学纯水溶性二胺和衍生物及其制备方法和用途
JP4744091B2 (ja) 2003-09-05 2011-08-10 関東化学株式会社 光学活性ニトロ化合物およびシアノ化合物の製造方法
GB2416167A (en) 2004-07-13 2006-01-18 Portela & Ca Sa Chiral inversion and esterification of (S)- and (R)-10-hydroxy-dibenzazepine carboxamides
GB2422149A (en) 2005-01-14 2006-07-19 Portela & Ca Sa Process for the preparation of 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide
GB0515690D0 (en) 2005-07-29 2005-09-07 Portela & Ca Sa Asymmetric catalytic reduction

Also Published As

Publication number Publication date
US20130041146A1 (en) 2013-02-14
ES2562816T3 (es) 2016-03-08
EP2319836A1 (en) 2011-05-11
EP2319836B1 (en) 2015-11-25
JP2013173764A (ja) 2013-09-05
US20160176823A1 (en) 2016-06-23
CN101277937A (zh) 2008-10-01
BRPI0615970A2 (pt) 2011-05-31
SI1915346T1 (sl) 2011-12-30
JP5295765B2 (ja) 2013-09-18
KR101362281B1 (ko) 2014-02-12
US9643929B2 (en) 2017-05-09
EP1915346A1 (en) 2008-04-30
EP1915346B1 (en) 2011-08-17
AU2006273874A8 (en) 2008-03-06
CA2616984A1 (en) 2007-02-01
PT103467A (pt) 2007-01-31
CA2616984C (en) 2017-09-26
PL1915346T3 (pl) 2012-01-31
US20170190668A1 (en) 2017-07-06
IL189062A0 (en) 2008-08-07
US20090203902A1 (en) 2009-08-13
AR055917A1 (es) 2007-09-12
JP2009502893A (ja) 2009-01-29
US8288532B2 (en) 2012-10-16
AU2006273874A1 (en) 2007-02-01
BRPI0615970A8 (pt) 2017-08-22
AU2006273874B2 (en) 2013-01-10
RU2439060C2 (ru) 2012-01-10
RU2008107718A (ru) 2009-09-10
GB0515690D0 (en) 2005-09-07
ES2371556T3 (es) 2012-01-05
WO2007012793A1 (en) 2007-02-01
CY1111988T1 (el) 2015-11-04
ATE520665T1 (de) 2011-09-15
US9206135B2 (en) 2015-12-08
KR20080036212A (ko) 2008-04-25
NZ565462A (en) 2010-02-26
PT103467B (pt) 2009-03-19
CN101277937B (zh) 2010-12-08
MX2008001291A (es) 2008-03-18
ZA200800986B (en) 2010-02-24

Similar Documents

Publication Publication Date Title
DK3225251T3 (da) Modulering af pro-neurotrofinaktivitet
IL189062A0 (en) Asymmetric catalytic reduction of oxcarbazepine
EP1845849A4 (en) EXISCELET FOR THE LEGS
EP1874239A4 (en) HALF-POWERED EXOSCELETT OF LOWER EXTREMITY
DE602006014780D1 (de) Wabenstruktur
FR2871075B1 (fr) Catalyseur
DK1778618T3 (da) Syntese af triethylentetraminer
DE602005020856D1 (de) Unterhose
DE602007013849D1 (de) Mikroreaktor
DE602006014486D1 (de) Wabenstruktur
EP1725269A4 (en) Catalytic radiofluorination
DE602007005033D1 (de) Verschlossene Wabenstruktur
DK1883469T3 (da) Katalysatorfremstilling
FI20065583L (fi) Taajuusmuuttaja
DE602006021652D1 (de) Wabenstruktur
DK2054363T3 (da) Asymmetrisk hydrogenering af 1,1,1-trifluoracetone
EP2645554A4 (en) CONVERTER
EP1849270A4 (en) INTER WORKING
DE602006015414D1 (de) Abgaskatalysator
DE602005010664D1 (de) Katalytische asymmetrische epoxydierung
DE602006020309D1 (de) Filtriervorrichtung
EP1974433A4 (en) CONVERTER
DE102006061847A8 (de) Ammoniakkonverter
DK1877102T3 (da) Tab-molekyler
DE602006015145D1 (de) Wabenstruktur